DNA scan for familial autism finds variants that disrupt gene activity in autistic kids
The world's largest DNA scan for familial autism has uncovered new genetic changes in autistic children that are often not present in their parents. Identified in less than 1 percent of the population, these rare variants occur nearly 20 percent more in autistic children. Published in the June 9 online edition of the journal Nature, the findings emphasize the need for larger study samples to illuminate the diverse genetic causes of the brain disorder. UCLA researchers from UCLA's David Geffen School of Medicine and Semel Institute for Neuroscience and Human Behavior were among the lead investigators on the three-year study by the Autism Genome Project, an international consortium of scientists from more than 60 institutions in 12 countries.
"We know that 10 million gene variants consistently exist in every individual's genome," said Rita Cantor, a UCLA professor of human genetics. "We used DNA chips to collect and analyze data on 1 million of these variations to shed light on how autism develops." Using blood samples from 996 elementary school–age children diagnosed on the autism spectrum from the United States, Canada and Europe, the scientific teams combed the children's DNA for rare deletions and duplications. In particular, they hunted for changes in the genetic information that a child inherits from each parent. The families consisted of parents with one autistic child.
"We discovered two striking things. First, the rare variants interfered nearly 20 percent more in the genes of autistic children than in the healthy children," said Dr. Daniel Geschwind, a professor of neurology and psychiatry who holds UCLA's Gordon and Virginia MacDonald Distinguished Chair in Human Genetics. "Second, we found a number of disruptions that are new, or de novo. The autistic child is the first in their family to carry that variant. The parents do not have it. "This suggests that tiny genetic errors may occur during formation of the parents' eggs and sperm, and these variations are copied in the creation of the child's DNA," added Geschwind, who is also director of the UCLA Center for Autism Research and Treatment. "The finding parallels what takes place in chromosomal disorders like Down syndrome." The study confirms earlier findings in smaller samples that some children carry private genetic mutations that are unique to them, contributing to their susceptibility to autism.
"We found many more disrupted genes in the autistic children than in the control group," said Dr. Stanley Nelson, a UCLA professor of human genetics and psychiatry. "But here's where it gets tricky — every child showed a different disturbance in a different gene. When we looked at the gene's function, however, certain categories of genes emerged that were more likely to be influenced by the mutation. "Three of the disrupted genes, for example, participate in cellular communication," Nelson said. "They all cluster at the synapse, the site where brain cells talk to each other. One of these genes has previously been tied to autism and intellectual disabilities."
The researchers' next step will be to uncover patterns by identifying groups of disrupted genes that work together in the body to establish key functions or biological processes. The results may reveal clues to where genes go awry and increase autism risk, offering hope for common treatments. In the meantime, families affected by autism can help advance research efforts by participating in future genetic studies. "This study's larger sample size enabled us to pinpoint rare variations that we could not have detected in a smaller group," Nelson emphasized. "Yet these findings explain only 3.3 percent of the genetic origins of autism. In order to identify all of autism's genetic causes, we need tens of thousands of families to volunteer their DNA samples for sequencing."
Many of the study's samples were provided by families who donated blood to the Los Angeles–based Autism Genetic Resource Exchange (AGRE), a gene bank created and funded by Cure Autism Now, (since renamed Autism Speaks), and a grant from the National Institute of Mental Health to the three UCLA authors, Cantor, Geschwind and Nelson. The consortium's research was funded by Autism Speaks (USA), the Hilibrand Foundation (USA), the Health Research Board (Ireland), the Medical Research Council (U.K.) and the Genome Canada/Ontario Genomics Institute. Additional support for individual groups was provided by the U.S. National Institutes of Health and equivalent federal agencies in Canada, France, Italy, the United Kingdom, Germany, Portugal and Sweden. A complete list of contributing authors and institutions is available in the Nature paper.
Autism is a complex brain disorder that strikes in early childhood. The condition disrupts a child's ability to communicate and develop social relationships and is often accompanied by acute behavioral challenges. Autism spectrum disorders are diagnosed in one in 110 children in the United States, affecting four times as many boys as girls. Diagnoses have expanded tenfold in the last decade. The UCLA Center for Autism Research and Treatment provides diagnosis, family counseling, clinical trials and treatment for patients with autism. UCLA is one of eight centers in the National Institutes of Health–funded Studies to Advance Autism Research and Treatment network and one of 10 original Collaborative Programs for Excellence in Autism.